SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001078782-20-000296
Filing Date
2020-04-29
Accepted
2020-04-29 16:31:49
Documents
6
Period of Report
2020-04-29
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE 14A PROXY STATEMENT def14a042420_def14a.htm DEF 14A 681820
2 IMAGE def14a042420def14a1.jpg GRAPHIC 291320
3 IMAGE def14a042420def14a2.jpg GRAPHIC 357330
4 IMAGE def14a042420def14a3.jpg GRAPHIC 144203
5 IMAGE def14a042420def14a4.jpg GRAPHIC 235708
6 IMAGE def14a042420def14a5.jpg GRAPHIC 165090
  Complete submission text file 0001078782-20-000296.txt   2327599
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36833 | Film No.: 20830826
SIC: 2835 In Vitro & In Vivo Diagnostic Substances